Superlatives are commonly used in news coverage of cancer drugs, study findsBMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h5803 (Published 02 November 2015) Cite this as: BMJ 2015;351:h5803
- Michael McCarthy
The use of superlatives such as “breakthrough,” “revolutionary,” and “groundbreaking” are common in news articles about cancer drugs, even in stories reporting results from mouse, cell culture, or other preclinical studies, US research has found.1
The study authors used Google’s news search to identify articles about cancer drugs in which superlatives appeared from 21 to 25 June this year, three weeks after the national meeting of the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial